14/10/24 (Agence Europe) – On Monday 14 October, the European Investment Bank (EIB) announced a €2 million loan to Akagera Medicines Africa Limited to support the development of early-stage vaccines in Rwanda. This new support will accelerate research and development and the manufacture of new vaccines to treat infectious diseases such as tuberculosis, HIV, Lassa fever and Ebola. This new funding will also be used to strengthen the technical skills and expertise of the teams based in...